ENTITY
Sumitomo Pharma

Sumitomo Pharma (4506 JP)

135
Analysis
Health Care • Japan
Sumitomo Dainippon Pharma Co., Ltd. mainly manufactures and markets pharmaceuticals for human and veterinary use. The Company also produces and sells livestock feeds, food additives, and chemical products, as well as conducts clinical pathology tests for animals. Sumitomo Dainippon Pharma conducts businesses across worldwide.
more
•14 Dec 2021 23:03

Hisamitsu Pharmaceutical (4530 JP): Focus Shifts to ADHD Treatment Patch and Other Upcoming Launches

While our bear case still holds good for the company, near-term focus is now shifting to new launches and upcoming approvals. Hisamitsu is expected...

Logo
433 Views
Share
•24 Mar 2020 03:11

JAPAN DELTA IV - Is The GPIF In Buying?

The GPIF is the world's largest pension fund at what was $1.6 trillion-plus at the end of December 2019. The management of the GPIF has made...

Logo
550 Views
Share
•29 Feb 2020 21:11
Smartkarma Originals

A Potential Asian LBO Screening System

With a relatively full slate of large value takeovers in Developed Asia in the past year - often by parents but also by buyout funds - and the...

Logo
1.5k Views
Share
•03 Sep 2019 16:36

Japan Short Interest - The Numb3rs

The short notional in the market for the week ended 30 August is US$24.65bn with the largest short positions in Itochu Corp (8001 JP), Toyota Motor...

Logo
608 Views
Share
•03 Feb 2019 18:32

Japan Fortnightly Update: Drip, Drip, Drip...

DRIP, DRIP, DRIP - We 'lead' this fortnight's update with our All-Market Composite Results & Revision Score. Calculated daily, the score is a...

Logo
562 Views
Share
x